FLNA
FILANA THERAPEUTICS, INC.
Company overview
- Market capitalization
- $41.22M
- Employees
- 17
- Latest publication
- 2026-09-29
About FILANA THERAPEUTICS, INC.
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 243,000USD | 367,000USD | — | — | — | — | — |
| Gross Profit | -243,000USD | -367,000USD | — | — | — | — | — |
| Research Development | 4,544,000USD | 3,853,000USD | 3,955,000USD | 5,116,000USD | 13,666,000USD | 20,530,000USD | 17,676,000USD |
| Selling General Administrative | 6,624,000USD | 9,699,000USD | 7,905,000USD | 40,276,000USD | 10,920,000USD | 8,957,000USD | 12,947,000USD |
| Total Operating Expenses | 10,925,000USD | 13,185,000USD | 11,860,000USD | 45,392,000USD | 24,586,000USD | 29,487,000USD | 30,623,000USD |
| Operating Income | -11,168,000USD | -13,552,000USD | -11,860,000USD | -45,392,000USD | -24,586,000USD | -29,487,000USD | -30,623,000USD |
| Interest Income | 789,000USD | 974,000USD | 1,167,000USD | 1,214,000USD | 1,265,000USD | 1,800,000USD | — |
| Net Interest Income | 789,000USD | 974,000USD | 1,167,000USD | 1,214,000USD | 1,265,000USD | 1,800,000USD | — |
| Income Before Tax | -10,331,000USD | -12,539,000USD | -10,807,000USD | -44,224,000USD | -23,403,000USD | -27,597,000USD | -27,943,000USD |
| Net Income | -10,331,000USD | -12,539,000USD | -10,807,000USD | -44,224,000USD | -23,403,000USD | -27,597,000USD | -27,943,000USD |
| Net Income From Continuing Ops | -10,331,000USD | -12,539,000USD | -10,807,000USD | -44,224,000USD | -23,403,000USD | -27,597,000USD | — |
| Ebit | -11,168,000USD | -13,552,000USD | -11,860,000USD | -45,392,000USD | -24,586,000USD | -30,319,000USD | -30,623,000USD |
| Ebitda | -10,925,000USD | -13,185,000USD | -11,729,000USD | -45,174,000USD | -24,366,000USD | -30,059,000USD | -30,364,000USD |
| Depreciation And Amortization | 243,000USD | 367,000USD | 131,000USD | 218,000USD | 220,000USD | 260,000USD | 259,000USD |
| Reconciled Depreciation | 243,000USD | 367,000USD | 131,000USD | 218,000USD | 220,000USD | 260,000USD | — |
| Total Other Income Expense Net | 837,000USD | 1,013,000USD | 1,053,000USD | 1,168,000USD | 1,183,000USD | 1,890,000USD | 2,680,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 936,000USD | — | — | — | — |
| Gross Profit | -936,000USD | — | — | — | — |
| Research Development | 26,590,000USD | 69,637,000USD | 89,423,000USD | 68,032,000USD | 24,813,000USD |
| Selling General Administrative | 68,800,000USD | 71,809,000USD | 16,534,000USD | 11,988,000USD | 8,055,000USD |
| Total Operating Expenses | 94,454,000USD | 141,446,000USD | 105,957,000USD | 80,020,000USD | 32,868,000USD |
| Operating Income | -95,390,000USD | -141,446,000USD | -105,957,000USD | -80,020,000USD | -32,868,000USD |
| Interest Income | 4,620,000USD | 8,510,000USD | 7,833,000USD | 2,777,000USD | — |
| Net Interest Income | 4,620,000USD | 8,510,000USD | 7,833,000USD | 2,777,000USD | — |
| Income Before Tax | -90,973,000USD | -24,342,000USD | -97,217,000USD | -76,246,000USD | -32,385,000USD |
| Net Income | -90,973,000USD | -24,342,000USD | -97,217,000USD | -76,246,000USD | -32,385,000USD |
| Net Income From Continuing Ops | -90,973,000USD | -24,342,000USD | -97,217,000USD | -76,246,000USD | — |
| Ebit | -95,390,000USD | -142,278,000USD | -107,333,000USD | -81,482,000USD | -32,868,000USD |
| Ebitda | -94,454,000USD | -141,146,000USD | -105,803,000USD | -80,181,000USD | -32,334,000USD |
| Depreciation And Amortization | 936,000USD | 1,132,000USD | 1,530,000USD | 1,301,000USD | 534,000USD |
| Reconciled Depreciation | 936,000USD | 1,132,000USD | 1,530,000USD | 1,301,000USD | — |
| Total Other Income Expense Net | 4,417,000USD | 117,104,000USD | 8,740,000USD | 3,774,000USD | 483,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 103,903,000USD | 108,367,000USD | 118,355,000USD | 129,733,000USD | 135,384,000USD | 140,932,000USD | 157,533,000USD | 223,753,000USD |
| Cash And Equivalents | 82,681,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 83,723,000USD | 87,964,000USD | 97,709,000USD | 108,910,000USD | 114,821,000USD | 120,151,000USD | 136,532,000USD | 202,549,000USD |
| Other Current Assets | 1,042,000USD | 1,274,000USD | 2,087,000USD | 2,013,000USD | 1,605,000USD | 1,959,000USD | 7,011,000USD | 47,296,000USD |
| Total Liabilities | 40,294,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 40,158,000USD | 40,115,000USD | 43,834,000USD | 48,046,000USD | 47,332,000USD | 13,237,000USD | 11,750,000USD | 57,034,000USD |
| Other Current Liabilities | 121,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 136,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 63,609,000USD | 68,141,000USD | 74,403,000USD | 81,568,000USD | 87,973,000USD | 127,616,000USD | 145,704,000USD | 166,639,000USD |
| Total Equity Including Noncontrolling Interest | 63,609,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 20,180,000USD | 20,403,000USD | 20,646,000USD | 20,823,000USD | 20,563,000USD | 20,781,000USD | 20,964,000USD | 21,135,000USD |
| Common Stock | 48,000USD | 48,000USD | 48,000USD | 48,000USD | 48,000USD | 48,000USD | 48,000USD | 48,000USD |
| Retained Earnings | -515,018,000USD | -506,415,000USD | -496,084,000USD | -483,545,000USD | -472,738,000USD | -428,514,000USD | -405,111,000USD | -377,514,000USD |
| Total Liab | — | 40,226,000USD | 43,952,000USD | 48,165,000USD | 47,411,000USD | 13,316,000USD | 11,829,000USD | 57,114,000USD |
| Other Current Liab | — | 926,000USD | 37,437,000USD | 1,954,000USD | 4,510,000USD | 5,045,000USD | 4,096,000USD | 4,790,000USD |
| Capital Stock | — | 48,000USD | 48,000USD | 48,000USD | 48,000USD | 48,000USD | 48,000USD | — |
| Cash | — | 86,573,000USD | 95,502,000USD | 106,080,000USD | 112,381,000USD | 117,328,000USD | 128,574,000USD | 148,978,000USD |
| Cash And Short Term Investments | — | 86,573,000USD | 95,502,000USD | 106,080,000USD | 112,381,000USD | 117,328,000USD | 128,574,000USD | 148,978,000USD |
| Net Debt | — | -86,573,000USD | -95,502,000USD | -106,080,000USD | -112,381,000USD | -117,328,000USD | -128,574,000USD | -148,978,000USD |
| Net Receivables | — | 117,000USD | 120,000USD | 817,000USD | 835,000USD | 864,000USD | 947,000USD | 6,275,000USD |
| Accounts Payable | — | 39,189,000USD | 6,397,000USD | 46,092,000USD | 42,822,000USD | 8,192,000USD | 7,654,000USD | 52,244,000USD |
| Property Plant Equipment Gross | — | 24,773,000USD | 24,785,000USD | 24,730,000USD | 24,227,000USD | 24,231,000USD | 24,237,000USD | — |
| Common Stock Shares Outstanding | — | 48,308,000shares | 48,308,000shares | 48,308,000shares | 48,308,000shares | 48,262,000shares | 4,809,900,000shares | 47,976,000shares |
| Non Current Assets Total | — | 20,403,000USD | 20,646,000USD | 20,823,000USD | 20,563,000USD | 20,781,000USD | 21,001,000USD | 21,204,000USD |
| Non Current Liabilities Total | — | 110,999USD | 117,999USD | 119,000USD | 79,000USD | 79,000USD | 79,000USD | 80,000USD |
| Non Current Liabilities Other | — | 111,000USD | 118,000USD | 119,000USD | 79,000USD | 79,000USD | 79,000USD | — |
| Net Working Capital | — | 47,849,000USD | 53,875,000USD | 60,864,000USD | 67,489,000USD | 106,914,000USD | 124,782,000USD | — |
| Unclassified Equity | — | 574,460,000USD | 570,391,000USD | 565,017,000USD | 560,615,000USD | 556,034,000USD | 550,719,000USD | 544,105,000USD |
| Intangible Assets | — | — | — | — | — | — | 37,000USD | 69,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 118,355,000USD | 157,533,000USD | 151,663,000USD | 234,834,000USD | — |
| Other Current Assets | 2,087,000USD | 38,000USD | 287,000USD | 160,000USD | — |
| Total Liab | 43,952,000USD | 11,829,000USD | 14,195,000USD | 7,295,000USD | — |
| Total Stockholder Equity | 74,403,000USD | 145,704,000USD | 137,468,000USD | 227,539,000USD | — |
| Other Current Liab | 37,437,000USD | 299,000USD | 385,000USD | 492,000USD | — |
| Common Stock | 48,000USD | — | — | — | — |
| Capital Stock | 48,000USD | 48,000USD | 42,000USD | 42,000USD | — |
| Retained Earnings | -496,084,000USD | -405,111,000USD | -380,769,000USD | -283,552,000USD | — |
| Cash | 95,502,000USD | 128,574,000USD | 121,136,000USD | 201,015,000USD | — |
| Cash And Short Term Investments | 95,502,000USD | — | — | — | — |
| Total Current Assets | 97,709,000USD | 136,532,000USD | 129,633,000USD | 211,226,000USD | — |
| Total Current Liabilities | 43,834,000USD | 11,750,000USD | 14,195,000USD | 7,063,000USD | — |
| Net Debt | -95,502,000USD | — | — | — | — |
| Net Receivables | 120,000USD | — | — | — | — |
| Accounts Payable | 6,397,000USD | 7,654,000USD | 10,573,000USD | 4,017,000USD | — |
| Property Plant Equipment Net | 20,646,000USD | 21,001,000USD | 21,854,000USD | 22,986,000USD | — |
| Property Plant Equipment Gross | 24,785,000USD | 24,237,000USD | 24,138,000USD | 24,186,000USD | — |
| Common Stock Shares Outstanding | 48,297,000shares | 4,660,400,000shares | 41,932,000shares | 40,202,000shares | 39,405,000shares |
| Non Current Assets Total | 20,646,000USD | 21,001,000USD | 22,030,000USD | 23,608,000USD | — |
| Non Current Liabilities Total | 117,999USD | 79,000USD | 0USD | 232,000USD | — |
| Non Current Liabilities Other | 118,000USD | 79,000USD | — | 197,000USD | — |
| Net Working Capital | 53,875,000USD | 124,782,000USD | 115,438,000USD | 204,163,000USD | — |
| Unclassified Equity | 570,391,000USD | 550,767,000USD | 518,195,000USD | 511,049,000USD | — |
| Intangible Assets | — | 37,000USD | 176,000USD | 622,000USD | — |
| Unclassified Current Assets | — | 7,920,000USD | 8,210,000USD | 10,051,000USD | — |
| Unclassified Current Liabilities | — | 3,797,000USD | 3,237,000USD | 2,554,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -10,331,000USD | -12,539,000USD | -10,807,000USD | -44,224,000USD | -23,403,000USD | -27,597,000USD | -27,943,000USD |
| Depreciation | 243,000USD | 367,000USD | 131,000USD | 218,000USD | 220,000USD | 260,000USD | 259,000USD |
| Stock Based Compensation | 4,069,000USD | 5,374,000USD | 4,402,000USD | 4,581,000USD | 5,225,000USD | 5,744,000USD | 5,608,000USD |
| Change In Working Capital | -2,859,000USD | -2,950,000USD | 53,000USD | 34,478,000USD | 6,622,000USD | -39,672,000USD | 3,780,000USD |
| Total Cash From Operating Activities | -8,878,000USD | -9,748,000USD | -6,221,000USD | -4,947,000USD | -11,336,000USD | -61,265,000USD | -18,296,000USD |
| Capital Expenditures | 0USD | -501,000USD | -80,000USD | 0USD | 0USD | -57,000USD | -17,000USD |
| Free Cash Flow | -8,878,000USD | -10,249,000USD | -6,301,000USD | -4,947,000USD | -11,336,000USD | -61,322,000USD | -18,313,000USD |
| Total Cash From Financing Activities | -51,000USD | -329,000USD | 0USD | 0USD | 90,000USD | 918,000USD | — |
| Change In Cash | -8,929,000USD | -10,578,000USD | -6,301,000USD | -4,947,000USD | -11,246,000USD | -60,404,000USD | -18,313,000USD |
| Begin Period Cash Flow | 95,502,000USD | 106,080,000USD | 112,381,000USD | 117,328,000USD | 128,574,000USD | 188,978,000USD | 207,291,000USD |
| End Period Cash Flow | 86,573,000USD | 95,502,000USD | 106,080,000USD | 112,381,000USD | 117,328,000USD | 128,574,000USD | 188,978,000USD |
| Other Non Cash Items | — | 5,374,000USD | — | — | 5,225,000USD | — | — |
| Total Cashflows From Investing Activities | — | -501,000USD | -80,000USD | — | — | -57,000USD | -17,000USD |
| Unclassified Operating Cash Flow | — | -5,374,000USD | — | — | -5,225,000USD | — | — |
| Other Cashflows From Financing Activities | — | — | — | — | — | 918,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Net Income | -90,973,000USD | -24,342,000USD | -97,217,000USD | -76,246,000USD |
| Depreciation | 936,000USD | 1,132,000USD | 1,530,000USD | 1,301,000USD |
| Stock Based Compensation | 19,582,000USD | 16,291,000USD | 4,586,000USD | 2,066,000USD |
| Other Non Cash Items | 19,582,000USD | — | — | — |
| Change In Working Capital | 38,203,000USD | -1,827,000USD | 9,076,000USD | -4,635,000USD |
| Total Cash From Operating Activities | -32,252,000USD | -116,929,000USD | -82,025,000USD | -77,514,000USD |
| Capital Expenditures | -581,000USD | -103,000USD | -414,000USD | -2,712,000USD |
| Free Cash Flow | -32,833,000USD | -117,032,000USD | -82,439,000USD | -80,226,000USD |
| Total Cashflows From Investing Activities | -581,000USD | — | — | — |
| Total Cash From Financing Activities | -239,000USD | 124,470,000USD | 2,560,000USD | 47,804,000USD |
| Change In Cash | -33,072,000USD | 7,438,000USD | -79,879,000USD | -32,422,000USD |
| Begin Period Cash Flow | 128,574,000USD | 121,136,000USD | 201,015,000USD | 233,437,000USD |
| End Period Cash Flow | 95,502,000USD | 128,574,000USD | 121,136,000USD | 201,015,000USD |
| Unclassified Operating Cash Flow | -19,582,000USD | -108,183,000USD | — | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | 47,329,000USD |
| Unclassified Financing Cash Flow | — | 124,470,000USD | 2,560,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.